[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Glutamate Receptor Ionotropic NMDA 2B Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

July 2024 | 88 pages | ID: GAA7B741B112EN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to our (Global Info Research) latest study, the global Glutamate Receptor Ionotropic NMDA 2B market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

The Global Info Research report includes an overview of the development of the Glutamate Receptor Ionotropic NMDA 2B industry chain, the market status of Acute Ischemic Stroke (JNJ-0808, Neu-2000), Autism (JNJ-0808, Neu-2000), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Glutamate Receptor Ionotropic NMDA 2B.

Regionally, the report analyzes the Glutamate Receptor Ionotropic NMDA 2B markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Glutamate Receptor Ionotropic NMDA 2B market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:

The report presents comprehensive understanding of the Glutamate Receptor Ionotropic NMDA 2B market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Glutamate Receptor Ionotropic NMDA 2B industry.

The report involves analyzing the market at a macro level:

Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Pcs), revenue generated, and market share of different by Type (e.g., JNJ-0808, Neu-2000).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Glutamate Receptor Ionotropic NMDA 2B market.

Regional Analysis: The report involves examining the Glutamate Receptor Ionotropic NMDA 2B market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Glutamate Receptor Ionotropic NMDA 2B market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Glutamate Receptor Ionotropic NMDA 2B:

Company Analysis: Report covers individual Glutamate Receptor Ionotropic NMDA 2B manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Glutamate Receptor Ionotropic NMDA 2B This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Acute Ischemic Stroke, Autism).

Technology Analysis: Report covers specific technologies relevant to Glutamate Receptor Ionotropic NMDA 2B. It assesses the current state, advancements, and potential future developments in Glutamate Receptor Ionotropic NMDA 2B areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Glutamate Receptor Ionotropic NMDA 2B market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation

Glutamate Receptor Ionotropic NMDA 2B market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
  • JNJ-0808
  • Neu-2000
  • NP-10679
  • NP-11948
  • Radiprodil
  • Others
Market segment by Application
  • Acute Ischemic Stroke
  • Autism
  • Brain Ischemia
  • Burns
  • Others
Major players covered
  • BioCrea GmbH
  • Bristol-Myers Squibb Company
  • Cerecor Inc.
  • Johnson & Johnson
  • Luc Therapeutics, Inc.
  • NeurOp, Inc
  • Novartis AG
  • UCB S.A.
Market segment by region, regional analysis covers
  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
  • South America (Brazil, Argentina, Colombia, and Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Glutamate Receptor Ionotropic NMDA 2B product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Glutamate Receptor Ionotropic NMDA 2B, with price, sales, revenue and global market share of Glutamate Receptor Ionotropic NMDA 2B from 2019 to 2024.

Chapter 3, the Glutamate Receptor Ionotropic NMDA 2B competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Glutamate Receptor Ionotropic NMDA 2B breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Glutamate Receptor Ionotropic NMDA 2B market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Glutamate Receptor Ionotropic NMDA 2B.

Chapter 14 and 15, to describe Glutamate Receptor Ionotropic NMDA 2B sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW

1.1 Product Overview and Scope of Glutamate Receptor Ionotropic NMDA 2B
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
  1.3.1 Overview: Global Glutamate Receptor Ionotropic NMDA 2B Consumption Value by Type: 2019 Versus 2023 Versus 2030
  1.3.2 JNJ-0808
  1.3.3 Neu-2000
  1.3.4 NP-10679
  1.3.5 NP-11948
  1.3.6 Radiprodil
  1.3.7 Others
1.4 Market Analysis by Application
  1.4.1 Overview: Global Glutamate Receptor Ionotropic NMDA 2B Consumption Value by Application: 2019 Versus 2023 Versus 2030
  1.4.2 Acute Ischemic Stroke
  1.4.3 Autism
  1.4.4 Brain Ischemia
  1.4.5 Burns
  1.4.6 Others
1.5 Global Glutamate Receptor Ionotropic NMDA 2B Market Size & Forecast
  1.5.1 Global Glutamate Receptor Ionotropic NMDA 2B Consumption Value (2019 & 2023 & 2030)
  1.5.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales Quantity (2019-2030)
  1.5.3 Global Glutamate Receptor Ionotropic NMDA 2B Average Price (2019-2030)

2 MANUFACTURERS PROFILES

2.1 BioCrea GmbH
  2.1.1 BioCrea GmbH Details
  2.1.2 BioCrea GmbH Major Business
  2.1.3 BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Product and Services
  2.1.4 BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.1.5 BioCrea GmbH Recent Developments/Updates
2.2 Bristol-Myers Squibb Company
  2.2.1 Bristol-Myers Squibb Company Details
  2.2.2 Bristol-Myers Squibb Company Major Business
  2.2.3 Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Product and Services
  2.2.4 Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.2.5 Bristol-Myers Squibb Company Recent Developments/Updates
2.3 Cerecor Inc.
  2.3.1 Cerecor Inc. Details
  2.3.2 Cerecor Inc. Major Business
  2.3.3 Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Product and Services
  2.3.4 Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.3.5 Cerecor Inc. Recent Developments/Updates
2.4 Johnson & Johnson
  2.4.1 Johnson & Johnson Details
  2.4.2 Johnson & Johnson Major Business
  2.4.3 Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Product and Services
  2.4.4 Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.4.5 Johnson & Johnson Recent Developments/Updates
2.5 Luc Therapeutics, Inc.
  2.5.1 Luc Therapeutics, Inc. Details
  2.5.2 Luc Therapeutics, Inc. Major Business
  2.5.3 Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Product and Services
  2.5.4 Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.5.5 Luc Therapeutics, Inc. Recent Developments/Updates
2.6 NeurOp, Inc
  2.6.1 NeurOp, Inc Details
  2.6.2 NeurOp, Inc Major Business
  2.6.3 NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Product and Services
  2.6.4 NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.6.5 NeurOp, Inc Recent Developments/Updates
2.7 Novartis AG
  2.7.1 Novartis AG Details
  2.7.2 Novartis AG Major Business
  2.7.3 Novartis AG Glutamate Receptor Ionotropic NMDA 2B Product and Services
  2.7.4 Novartis AG Glutamate Receptor Ionotropic NMDA 2B Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.7.5 Novartis AG Recent Developments/Updates
2.8 UCB S.A.
  2.8.1 UCB S.A. Details
  2.8.2 UCB S.A. Major Business
  2.8.3 UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Product and Services
  2.8.4 UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
  2.8.5 UCB S.A. Recent Developments/Updates

3 COMPETITIVE ENVIRONMENT: GLUTAMATE RECEPTOR IONOTROPIC NMDA 2B BY MANUFACTURER

3.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Manufacturer (2019-2024)
3.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Manufacturer (2019-2024)
3.3 Global Glutamate Receptor Ionotropic NMDA 2B Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
  3.4.1 Producer Shipments of Glutamate Receptor Ionotropic NMDA 2B by Manufacturer Revenue ($MM) and Market Share (%): 2023
  3.4.2 Top 3 Glutamate Receptor Ionotropic NMDA 2B Manufacturer Market Share in 2023
  3.4.2 Top 6 Glutamate Receptor Ionotropic NMDA 2B Manufacturer Market Share in 2023
3.5 Glutamate Receptor Ionotropic NMDA 2B Market: Overall Company Footprint Analysis
  3.5.1 Glutamate Receptor Ionotropic NMDA 2B Market: Region Footprint
  3.5.2 Glutamate Receptor Ionotropic NMDA 2B Market: Company Product Type Footprint
  3.5.3 Glutamate Receptor Ionotropic NMDA 2B Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 CONSUMPTION ANALYSIS BY REGION

4.1 Global Glutamate Receptor Ionotropic NMDA 2B Market Size by Region
  4.1.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Region (2019-2030)
  4.1.2 Global Glutamate Receptor Ionotropic NMDA 2B Consumption Value by Region (2019-2030)
  4.1.3 Global Glutamate Receptor Ionotropic NMDA 2B Average Price by Region (2019-2030)
4.2 North America Glutamate Receptor Ionotropic NMDA 2B Consumption Value (2019-2030)
4.3 Europe Glutamate Receptor Ionotropic NMDA 2B Consumption Value (2019-2030)
4.4 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Consumption Value (2019-2030)
4.5 South America Glutamate Receptor Ionotropic NMDA 2B Consumption Value (2019-2030)
4.6 Middle East and Africa Glutamate Receptor Ionotropic NMDA 2B Consumption Value (2019-2030)

5 MARKET SEGMENT BY TYPE

5.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Type (2019-2030)
5.2 Global Glutamate Receptor Ionotropic NMDA 2B Consumption Value by Type (2019-2030)
5.3 Global Glutamate Receptor Ionotropic NMDA 2B Average Price by Type (2019-2030)

6 MARKET SEGMENT BY APPLICATION

6.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Application (2019-2030)
6.2 Global Glutamate Receptor Ionotropic NMDA 2B Consumption Value by Application (2019-2030)
6.3 Global Glutamate Receptor Ionotropic NMDA 2B Average Price by Application (2019-2030)

7 NORTH AMERICA

7.1 North America Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Type (2019-2030)
7.2 North America Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Application (2019-2030)
7.3 North America Glutamate Receptor Ionotropic NMDA 2B Market Size by Country
  7.3.1 North America Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Country (2019-2030)
  7.3.2 North America Glutamate Receptor Ionotropic NMDA 2B Consumption Value by Country (2019-2030)
  7.3.3 United States Market Size and Forecast (2019-2030)
  7.3.4 Canada Market Size and Forecast (2019-2030)
  7.3.5 Mexico Market Size and Forecast (2019-2030)

8 EUROPE

8.1 Europe Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Type (2019-2030)
8.2 Europe Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Application (2019-2030)
8.3 Europe Glutamate Receptor Ionotropic NMDA 2B Market Size by Country
  8.3.1 Europe Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Country (2019-2030)
  8.3.2 Europe Glutamate Receptor Ionotropic NMDA 2B Consumption Value by Country (2019-2030)
  8.3.3 Germany Market Size and Forecast (2019-2030)
  8.3.4 France Market Size and Forecast (2019-2030)
  8.3.5 United Kingdom Market Size and Forecast (2019-2030)
  8.3.6 Russia Market Size and Forecast (2019-2030)
  8.3.7 Italy Market Size and Forecast (2019-2030)

9 ASIA-PACIFIC

9.1 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Market Size by Region
  9.3.1 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Region (2019-2030)
  9.3.2 Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Consumption Value by Region (2019-2030)
  9.3.3 China Market Size and Forecast (2019-2030)
  9.3.4 Japan Market Size and Forecast (2019-2030)
  9.3.5 Korea Market Size and Forecast (2019-2030)
  9.3.6 India Market Size and Forecast (2019-2030)
  9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
  9.3.8 Australia Market Size and Forecast (2019-2030)

10 SOUTH AMERICA

10.1 South America Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Type (2019-2030)
10.2 South America Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Application (2019-2030)
10.3 South America Glutamate Receptor Ionotropic NMDA 2B Market Size by Country
  10.3.1 South America Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Country (2019-2030)
  10.3.2 South America Glutamate Receptor Ionotropic NMDA 2B Consumption Value by Country (2019-2030)
  10.3.3 Brazil Market Size and Forecast (2019-2030)
  10.3.4 Argentina Market Size and Forecast (2019-2030)

11 MIDDLE EAST & AFRICA

11.1 Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Market Size by Country
  11.3.1 Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Country (2019-2030)
  11.3.2 Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Consumption Value by Country (2019-2030)
  11.3.3 Turkey Market Size and Forecast (2019-2030)
  11.3.4 Egypt Market Size and Forecast (2019-2030)
  11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
  11.3.6 South Africa Market Size and Forecast (2019-2030)

12 MARKET DYNAMICS

12.1 Glutamate Receptor Ionotropic NMDA 2B Market Drivers
12.2 Glutamate Receptor Ionotropic NMDA 2B Market Restraints
12.3 Glutamate Receptor Ionotropic NMDA 2B Trends Analysis
12.4 Porters Five Forces Analysis
  12.4.1 Threat of New Entrants
  12.4.2 Bargaining Power of Suppliers
  12.4.3 Bargaining Power of Buyers
  12.4.4 Threat of Substitutes
  12.4.5 Competitive Rivalry

13 RAW MATERIAL AND INDUSTRY CHAIN

13.1 Raw Material of Glutamate Receptor Ionotropic NMDA 2B and Key Manufacturers
13.2 Manufacturing Costs Percentage of Glutamate Receptor Ionotropic NMDA 2B
13.3 Glutamate Receptor Ionotropic NMDA 2B Production Process
13.4 Glutamate Receptor Ionotropic NMDA 2B Industrial Chain

14 SHIPMENTS BY DISTRIBUTION CHANNEL

14.1 Sales Channel
  14.1.1 Direct to End-User
  14.1.2 Distributors
14.2 Glutamate Receptor Ionotropic NMDA 2B Typical Distributors
14.3 Glutamate Receptor Ionotropic NMDA 2B Typical Customers

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

LIST OF TABLES

Table 1. Global Glutamate Receptor Ionotropic NMDA 2B Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Glutamate Receptor Ionotropic NMDA 2B Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. BioCrea GmbH Basic Information, Manufacturing Base and Competitors
Table 4. BioCrea GmbH Major Business
Table 5. BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Product and Services
Table 6. BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. BioCrea GmbH Recent Developments/Updates
Table 8. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 9. Bristol-Myers Squibb Company Major Business
Table 10. Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Product and Services
Table 11. Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Bristol-Myers Squibb Company Recent Developments/Updates
Table 13. Cerecor Inc. Basic Information, Manufacturing Base and Competitors
Table 14. Cerecor Inc. Major Business
Table 15. Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Product and Services
Table 16. Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Cerecor Inc. Recent Developments/Updates
Table 18. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 19. Johnson & Johnson Major Business
Table 20. Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Product and Services
Table 21. Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Johnson & Johnson Recent Developments/Updates
Table 23. Luc Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors
Table 24. Luc Therapeutics, Inc. Major Business
Table 25. Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Product and Services
Table 26. Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Luc Therapeutics, Inc. Recent Developments/Updates
Table 28. NeurOp, Inc Basic Information, Manufacturing Base and Competitors
Table 29. NeurOp, Inc Major Business
Table 30. NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Product and Services
Table 31. NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. NeurOp, Inc Recent Developments/Updates
Table 33. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 34. Novartis AG Major Business
Table 35. Novartis AG Glutamate Receptor Ionotropic NMDA 2B Product and Services
Table 36. Novartis AG Glutamate Receptor Ionotropic NMDA 2B Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Novartis AG Recent Developments/Updates
Table 38. UCB S.A. Basic Information, Manufacturing Base and Competitors
Table 39. UCB S.A. Major Business
Table 40. UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Product and Services
Table 41. UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. UCB S.A. Recent Developments/Updates
Table 43. Global Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Manufacturer (2019-2024) & (K Pcs)
Table 44. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Manufacturer (2019-2024) & (USD Million)
Table 45. Global Glutamate Receptor Ionotropic NMDA 2B Average Price by Manufacturer (2019-2024) & (USD/Pcs)
Table 46. Market Position of Manufacturers in Glutamate Receptor Ionotropic NMDA 2B, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 47. Head Office and Glutamate Receptor Ionotropic NMDA 2B Production Site of Key Manufacturer
Table 48. Glutamate Receptor Ionotropic NMDA 2B Market: Company Product Type Footprint
Table 49. Glutamate Receptor Ionotropic NMDA 2B Market: Company Product Application Footprint
Table 50. Glutamate Receptor Ionotropic NMDA 2B New Market Entrants and Barriers to Market Entry
Table 51. Glutamate Receptor Ionotropic NMDA 2B Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Region (2019-2024) & (K Pcs)
Table 53. Global Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Region (2025-2030) & (K Pcs)
Table 54. Global Glutamate Receptor Ionotropic NMDA 2B Consumption Value by Region (2019-2024) & (USD Million)
Table 55. Global Glutamate Receptor Ionotropic NMDA 2B Consumption Value by Region (2025-2030) & (USD Million)
Table 56. Global Glutamate Receptor Ionotropic NMDA 2B Average Price by Region (2019-2024) & (USD/Pcs)
Table 57. Global Glutamate Receptor Ionotropic NMDA 2B Average Price by Region (2025-2030) & (USD/Pcs)
Table 58. Global Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Type (2019-2024) & (K Pcs)
Table 59. Global Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Type (2025-2030) & (K Pcs)
Table 60. Global Glutamate Receptor Ionotropic NMDA 2B Consumption Value by Type (2019-2024) & (USD Million)
Table 61. Global Glutamate Receptor Ionotropic NMDA 2B Consumption Value by Type (2025-2030) & (USD Million)
Table 62. Global Glutamate Receptor Ionotropic NMDA 2B Average Price by Type (2019-2024) & (USD/Pcs)
Table 63. Global Glutamate Receptor Ionotropic NMDA 2B Average Price by Type (2025-2030) & (USD/Pcs)
Table 64. Global Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Application (2019-2024) & (K Pcs)
Table 65. Global Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Application (2025-2030) & (K Pcs)
Table 66. Global Glutamate Receptor Ionotropic NMDA 2B Consumption Value by Application (2019-2024) & (USD Million)
Table 67. Global Glutamate Receptor Ionotropic NMDA 2B Consumption Value by Application (2025-2030) & (USD Million)
Table 68. Global Glutamate Receptor Ionotropic NMDA 2B Average Price by Application (2019-2024) & (USD/Pcs)
Table 69. Global Glutamate Receptor Ionotropic NMDA 2B Average Price by Application (2025-2030) & (USD/Pcs)
Table 70. North America Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Type (2019-2024) & (K Pcs)
Table 71. North America Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Type (2025-2030) & (K Pcs)
Table 72. North America Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Application (2019-2024) & (K Pcs)
Table 73. North America Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Application (2025-2030) & (K Pcs)
Table 74. North America Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Country (2019-2024) & (K Pcs)
Table 75. North America Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Country (2025-2030) & (K Pcs)
Table 76. North America Glutamate Receptor Ionotropic NMDA 2B Consumption Value by Country (2019-2024) & (USD Million)
Table 77. North America Glutamate Receptor Ionotropic NMDA 2B Consumption Value by Country (2025-2030) & (USD Million)
Table 78. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Type (2019-2024) & (K Pcs)
Table 79. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Type (2025-2030) & (K Pcs)
Table 80. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Application (2019-2024) & (K Pcs)
Table 81. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Application (2025-2030) & (K Pcs)
Table 82. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Country (2019-2024) & (K Pcs)
Table 83. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Country (2025-2030) & (K Pcs)
Table 84. Europe Glutamate Receptor Ionotropic NMDA 2B Consumption Value by Country (2019-2024) & (USD Million)
Table 85. Europe Glutamate Receptor Ionotropic NMDA 2B Consumption Value by Country (2025-2030) & (USD Million)
Table 86. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Type (2019-2024) & (K Pcs)
Table 87. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Type (2025-2030) & (K Pcs)
Table 88. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Application (2019-2024) & (K Pcs)
Table 89. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Application (2025-2030) & (K Pcs)
Table 90. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Region (2019-2024) & (K Pcs)
Table 91. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Region (2025-2030) & (K Pcs)
Table 92. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Consumption Value by Region (2019-2024) & (USD Million)
Table 93. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Consumption Value by Region (2025-2030) & (USD Million)
Table 94. South America Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Type (2019-2024) & (K Pcs)
Table 95. South America Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Type (2025-2030) & (K Pcs)
Table 96. South America Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Application (2019-2024) & (K Pcs)
Table 97. South America Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Application (2025-2030) & (K Pcs)
Table 98. South America Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Country (2019-2024) & (K Pcs)
Table 99. South America Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Country (2025-2030) & (K Pcs)
Table 100. South America Glutamate Receptor Ionotropic NMDA 2B Consumption Value by Country (2019-2024) & (USD Million)
Table 101. South America Glutamate Receptor Ionotropic NMDA 2B Consumption Value by Country (2025-2030) & (USD Million)
Table 102. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Type (2019-2024) & (K Pcs)
Table 103. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Type (2025-2030) & (K Pcs)
Table 104. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Application (2019-2024) & (K Pcs)
Table 105. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Application (2025-2030) & (K Pcs)
Table 106. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Region (2019-2024) & (K Pcs)
Table 107. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales Quantity by Region (2025-2030) & (K Pcs)
Table 108. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Consumption Value by Region (2019-2024) & (USD Million)
Table 109. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Consumption Value by Region (2025-2030) & (USD Million)
Table 110. Glutamate Receptor Ionotropic NMDA 2B Raw Material
Table 111. Key Manufacturers of Glutamate Receptor Ionotropic NMDA 2B Raw Materials
Table 112. Glutamate Receptor Ionotropic NMDA 2B Typical Distributors
Table 113. Glutamate Receptor Ionotropic NMDA 2B Typical Customers

LIST OF FIGURES

Figure 1. Glutamate Receptor Ionotropic NMDA 2B Picture
Figure 2. Global Glutamate Receptor Ionotropic NMDA 2B Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Glutamate Receptor Ionotropic NMDA 2B Consumption Value Market Share by Type in 2023
Figure 4. JNJ-0808 Examples
Figure 5. Neu-2000 Examples
Figure 6. NP-10679 Examples
Figure 7. NP-11948 Examples
Figure 8. Radiprodil Examples
Figure 9. Others Examples
Figure 10. Global Glutamate Receptor Ionotropic NMDA 2B Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 11. Global Glutamate Receptor Ionotropic NMDA 2B Consumption Value Market Share by Application in 2023
Figure 12. Acute Ischemic Stroke Examples
Figure 13. Autism Examples
Figure 14. Brain Ischemia Examples
Figure 15. Burns Examples
Figure 16. Others Examples
Figure 17. Global Glutamate Receptor Ionotropic NMDA 2B Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 18. Global Glutamate Receptor Ionotropic NMDA 2B Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 19. Global Glutamate Receptor Ionotropic NMDA 2B Sales Quantity (2019-2030) & (K Pcs)
Figure 20. Global Glutamate Receptor Ionotropic NMDA 2B Average Price (2019-2030) & (USD/Pcs)
Figure 21. Global Glutamate Receptor Ionotropic NMDA 2B Sales Quantity Market Share by Manufacturer in 2023
Figure 22. Global Glutamate Receptor Ionotropic NMDA 2B Consumption Value Market Share by Manufacturer in 2023
Figure 23. Producer Shipments of Glutamate Receptor Ionotropic NMDA 2B by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 24. Top 3 Glutamate Receptor Ionotropic NMDA 2B Manufacturer (Consumption Value) Market Share in 2023
Figure 25. Top 6 Glutamate Receptor Ionotropic NMDA 2B Manufacturer (Consumption Value) Market Share in 2023
Figure 26. Global Glutamate Receptor Ionotropic NMDA 2B Sales Quantity Market Share by Region (2019-2030)
Figure 27. Global Glutamate Receptor Ionotropic NMDA 2B Consumption Value Market Share by Region (2019-2030)
Figure 28. North America Glutamate Receptor Ionotropic NMDA 2B Consumption Value (2019-2030) & (USD Million)
Figure 29. Europe Glutamate Receptor Ionotropic NMDA 2B Consumption Value (2019-2030) & (USD Million)
Figure 30. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Consumption Value (2019-2030) & (USD Million)
Figure 31. South America Glutamate Receptor Ionotropic NMDA 2B Consumption Value (2019-2030) & (USD Million)
Figure 32. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Consumption Value (2019-2030) & (USD Million)
Figure 33. Global Glutamate Receptor Ionotropic NMDA 2B Sales Quantity Market Share by Type (2019-2030)
Figure 34. Global Glutamate Receptor Ionotropic NMDA 2B Consumption Value Market Share by Type (2019-2030)
Figure 35. Global Glutamate Receptor Ionotropic NMDA 2B Average Price by Type (2019-2030) & (USD/Pcs)
Figure 36. Global Glutamate Receptor Ionotropic NMDA 2B Sales Quantity Market Share by Application (2019-2030)
Figure 37. Global Glutamate Receptor Ionotropic NMDA 2B Consumption Value Market Share by Application (2019-2030)
Figure 38. Global Glutamate Receptor Ionotropic NMDA 2B Average Price by Application (2019-2030) & (USD/Pcs)
Figure 39. North America Glutamate Receptor Ionotropic NMDA 2B Sales Quantity Market Share by Type (2019-2030)
Figure 40. North America Glutamate Receptor Ionotropic NMDA 2B Sales Quantity Market Share by Application (2019-2030)
Figure 41. North America Glutamate Receptor Ionotropic NMDA 2B Sales Quantity Market Share by Country (2019-2030)
Figure 42. North America Glutamate Receptor Ionotropic NMDA 2B Consumption Value Market Share by Country (2019-2030)
Figure 43. United States Glutamate Receptor Ionotropic NMDA 2B Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. Canada Glutamate Receptor Ionotropic NMDA 2B Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. Mexico Glutamate Receptor Ionotropic NMDA 2B Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Quantity Market Share by Type (2019-2030)
Figure 47. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Quantity Market Share by Application (2019-2030)
Figure 48. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Quantity Market Share by Country (2019-2030)
Figure 49. Europe Glutamate Receptor Ionotropic NMDA 2B Consumption Value Market Share by Country (2019-2030)
Figure 50. Germany Glutamate Receptor Ionotropic NMDA 2B Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. France Glutamate Receptor Ionotropic NMDA 2B Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. United Kingdom Glutamate Receptor Ionotropic NMDA 2B Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Russia Glutamate Receptor Ionotropic NMDA 2B Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Italy Glutamate Receptor Ionotropic NMDA 2B Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Quantity Market Share by Type (2019-2030)
Figure 56. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Quantity Market Share by Application (2019-2030)
Figure 57. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Sales Quantity Market Share by Region (2019-2030)
Figure 58. Asia-Pacific Glutamate Receptor Ionotropic NMDA 2B Consumption Value Market Share by Region (2019-2030)
Figure 59. China Glutamate Receptor Ionotropic NMDA 2B Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Japan Glutamate Receptor Ionotropic NMDA 2B Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Korea Glutamate Receptor Ionotropic NMDA 2B Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. India Glutamate Receptor Ionotropic NMDA 2B Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Southeast Asia Glutamate Receptor Ionotropic NMDA 2B Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Australia Glutamate Receptor Ionotropic NMDA 2B Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. South America Glutamate Receptor Ionotropic NMDA 2B Sales Quantity Market Share by Type (2019-2030)
Figure 66. South America Glutamate Receptor Ionotropic NMDA 2B Sales Quantity Market Share by Application (2019-2030)
Figure 67. South America Glutamate Receptor Ionotropic NMDA 2B Sales Quantity Market Share by Country (2019-2030)
Figure 68. South America Glutamate Receptor Ionotropic NMDA 2B Consumption Value Market Share by Country (2019-2030)
Figure 69. Brazil Glutamate Receptor Ionotropic NMDA 2B Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Argentina Glutamate Receptor Ionotropic NMDA 2B Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales Quantity Market Share by Type (2019-2030)
Figure 72. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales Quantity Market Share by Application (2019-2030)
Figure 73. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales Quantity Market Share by Region (2019-2030)
Figure 74. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Consumption Value Market Share by Region (2019-2030)
Figure 75. Turkey Glutamate Receptor Ionotropic NMDA 2B Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Egypt Glutamate Receptor Ionotropic NMDA 2B Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 77. Saudi Arabia Glutamate Receptor Ionotropic NMDA 2B Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 78. South Africa Glutamate Receptor Ionotropic NMDA 2B Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 79. Glutamate Receptor Ionotropic NMDA 2B Market Drivers
Figure 80. Glutamate Receptor Ionotropic NMDA 2B Market Restraints
Figure 81. Glutamate Receptor Ionotropic NMDA 2B Market Trends
Figure 82. Porters Five Forces Analysis
Figure 83. Manufacturing Cost Structure Analysis of Glutamate Receptor Ionotropic NMDA 2B in 2023
Figure 84. Manufacturing Process Analysis of Glutamate Receptor Ionotropic NMDA 2B
Figure 85. Glutamate Receptor Ionotropic NMDA 2B Industrial Chain
Figure 86. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 87. Direct Channel Pros & Cons
Figure 88. Indirect Channel Pros & Cons
Figure 89. Methodology
Figure 90. Research Process and Data Source


More Publications